Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Ma

Showing results (1-10 of 357) with videos related to

Pageof 36
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 31, 2021
To Stop or Not to Stop? Predicting Relapse After Anti-TNF Cessation in Patients With Crohn's DiseaseChristopher Ma
The American Journal of Gastroenterology|February 17, 2023
Applying Placebo and Nocebo Effects From Randomized Trials to Clinical Care and Future StudiesChristopher Ma
Gastroenterology|February 6, 2025
Mirikizumab for Crohn's Disease: Small Step Forward or Giant Leap Ahead?Christopher Ma
The Lancet. Gastroenterology & Hepatology|October 8, 2020
Harnessing localised delivery of gut-selective therapy for ulcerative colitisChristopher Ma, Remo Panaccione
Expert Opinion on Biological Therapy|December 26, 2019
Is there room for immunomodulators in ulcerative colitis?Tarun Chhibba, Christopher Ma
Gastroenterology|May 7, 2016
A Rare Cause of Chronic Abdominal PainChristopher Ma, Lawrence M Price
Digestive Diseases and Sciences|March 19, 2025
Impact of the Underutilization of Vibration-Controlled Transient Elastography in MASLD Patients Without Insurance CoverageChristopher Ma, David S Goldberg
The Lancet. Rheumatology|January 26, 2024
Making a big impact with small datasets using machine-learning approachesMay Y Choi, Christopher Ma
The Lancet. Gastroenterology & Hepatology|December 2, 2021
Integrating novel therapies into the management of moderate-to-severe ulcerative colitis: challenges and opportunitiesChristopher Ma, May Y Choi
Expert Opinion on Biological Therapy|March 13, 2025
IL23p19 therapies for moderately-to-severely active ulcerative colitisNewaz Shubidito Ahmed, Christopher Ma
Pageof 36

Showing results (1-10 of 357) with videos related to

Sort By:
Pageof 36
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 31, 2021
To Stop or Not to Stop? Predicting Relapse After Anti-TNF Cessation in Patients With Crohn's DiseaseChristopher Ma
The American Journal of Gastroenterology|February 17, 2023
Applying Placebo and Nocebo Effects From Randomized Trials to Clinical Care and Future StudiesChristopher Ma
Gastroenterology|February 6, 2025
Mirikizumab for Crohn's Disease: Small Step Forward or Giant Leap Ahead?Christopher Ma
The Lancet. Gastroenterology & Hepatology|October 8, 2020
Harnessing localised delivery of gut-selective therapy for ulcerative colitisChristopher Ma, Remo Panaccione
Expert Opinion on Biological Therapy|December 26, 2019
Is there room for immunomodulators in ulcerative colitis?Tarun Chhibba, Christopher Ma
Gastroenterology|May 7, 2016
A Rare Cause of Chronic Abdominal PainChristopher Ma, Lawrence M Price
Digestive Diseases and Sciences|March 19, 2025
Impact of the Underutilization of Vibration-Controlled Transient Elastography in MASLD Patients Without Insurance CoverageChristopher Ma, David S Goldberg
The Lancet. Rheumatology|January 26, 2024
Making a big impact with small datasets using machine-learning approachesMay Y Choi, Christopher Ma
The Lancet. Gastroenterology & Hepatology|December 2, 2021
Integrating novel therapies into the management of moderate-to-severe ulcerative colitis: challenges and opportunitiesChristopher Ma, May Y Choi
Expert Opinion on Biological Therapy|March 13, 2025
IL23p19 therapies for moderately-to-severely active ulcerative colitisNewaz Shubidito Ahmed, Christopher Ma
Pageof 36